Oprozomib
Oprozomib (ONX-0912; PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.6092
Molecular Formula
C25H32N4O7S
Notes
Research use only, not for human use.
Receptor
20Sproteasome
CAS Number
935888-69-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ADC-W-1633 1 mg
Anti-MUC1 (Nacolomab tafenatox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC
Ask
View Details 
MBS6136199-01 0.1 mL
DDX26 (Integrator Complex Subunit 6, DBI-1, Protein DDX26, Protein Deleted in Cancer 1, DICE1, INTS6, DBI1, DDX26A) APC
Ask
View Details 
MBS6136199-02 5x 0.1 mL
DDX26 (Integrator Complex Subunit 6, DBI-1, Protein DDX26, Protein Deleted in Cancer 1, DICE1, INTS6, DBI1, DDX26A) APC
Ask
View Details